Overview

This trial is active, not recruiting.

Conditions rectal cancer, colon rectal resection
Treatments high tie of ima, low tie of ima
Phase phase 3
Sponsor Shoichi Fujii, MD, PhD
Start date July 2006
End date September 2012
Trial size 331 participants
Trial identifier NCT01861678, YCUMC-D1108013, YokohamaCUMC424

Summary

The tying at a radix of the inferior mesenteric artery (IMA) is recognized as radical cure technique in a rectal cancer surgery in Japan. In one side, the preserving the left colic artery (LCA) that is the technique to maintain blood flow of proximal sigmoid colon is performed in practice. However, there is no evidence that shows effectiveness of this technique.

We conducted a randomized trial that compared between high tie and low tie of the IMA in rectal anterior resection to define an appropriate portion of IMA tying.

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Allocation randomized
Endpoint classification efficacy study
Intervention model parallel assignment
Masking open label
Primary purpose treatment
Arm
(Active Comparator)
In High tie group, IMA was transected at its origin from the abdominal aorta.
high tie of ima High tie
Conventional technique
(Experimental)
In the low tie of the IMA, IMA was separated after branching to the left colic artery. The lymph node dissection around the IMA at its origin was performed.
low tie of ima Low tie
Technique for preserving left colic arterial perfusion

Primary Outcomes

Measure
Anastomotic leakage rate
time frame: 14 days after surgery

Secondary Outcomes

Measure
Overall survival
time frame: 5 years
Operation time
time frame: 1 day after surgery
Amount of blood loss
time frame: 1 day after surgery

Eligibility Criteria

Male or female participants at least 20 years old.

Inclusion Criteria: - Age of 20 years old or over - Anterior resection is scheduled for rectal cancer and rectosigmoid cancer preoperatively. - Histologically proven adenocarcinoma - Clinical tumor penetrates visceral peritoneum (T4a), no metastasis (M0) or lower T factor - Elective operation - Tolerable surgery under general anesthesia - No history of laparotomy for colorectal resection except appendectomy - Provided written informed consent Exclusion Criteria: - Synchronous or metachronous (within 5 years) malignancy in another organ except carcinoma in situ - Multiple colorectal cancer that needs reconstruction two or more times - Acute intestinal obstruction or perforation due to rectal cancer - Pregnant or lactating women

Additional Information

Official title Randomized Controlled Trial to Evaluate High Tie Versus Low Tie of the Inferior Mesenteric Artery in Rectal Anterior Resection for Rectal Cancer Patients
Description Patients - This was a randomized controlled trial conducted at a single institute, which was Yokohama City University Medical Center (Japan). - 300 patients who underwent anterior resection for rectal cancer were randomly allocated to receive high tie or low tie of the inferior mesenteric artery. Surgical procedures - All surgical procedures were performed by one specialized colorectal treatment team. The laparoscopic surgeries were performed by a surgeon who passed the skill accreditation system for laparoscopic gastroenterological surgery was established by the Japanese Society for Endoscopic Surgery (JSES), and all open surgeries were performed under the supervision of these skillful surgeons. - All operations were performed according to the standard radical cure procedure described in the seventh edition of the Japanese General Rules for Clinical and Pathological Studies on Cancer of the Colon, Rectum and Anus. That is, intestinal excision with lymph node dissection around the IMA at its origin was performed in all surgical procedures. Patients who underwent palliative partial excision were not included. - In the high tie (HT) of the IMA, IMA was separated at its origin from the abdominal aorta. - In the low tie (LT) of the IMA, IMA was separated after branching to the left colic artery. The lymph node dissection around the IMA at its origin was performed. Randomization - To balance the operative backgrounds between HT and LT groups, the patients were stratified by the approach of surgery (open or laparoscopic surgery). Adjuvant therapy - When the pathological stage was diagnosed as stage 3 by histological examination of the resected specimen, adjuvant chemotherapy was done with oral fluoropyrimidine anti-cancer drug. - Neither radiation therapy nor preoperative chemotherapy was given to any patient. Preoperative chemo-radiotherapy even for rectal cancer is not yet standard treatment in Japan. Assessment parameters - The preoperative parameters - Operative assessment parameters - Postoperative assessment parameters An early postoperative complication was defined as a complication that occurred between the finish of the operation and postoperative day 30. A late postoperative complication was defined as a complication that occurred after postoperative day 30. The terminologies of complications were classified according to the Common Terminology Criteria for Adverse Events (CTCAE) version 4.0, and grading was done by Classification of Surgical Complication. - The pathological results were recorded according to the 7th edition of the Japanese General Rules for Clinical and Pathological Studies on Cancer of the Colon, Rectum and Anus and 7th edition of primary tumor, regional nodes, metastasis (TNM) classification. Circumferential margin involvement was defined as exposure of a cancer cell at the vertical dissection surface on histological examination. Follow-up schedule - The follow-up schedule was as follows according to stage. Patients with stages 0 and 1 were followed up with outpatient examinations including tumor marker measurements, and chest, abdominal and pelvic computed tomography (CT) once a year for five years. Patients with stage 2 and 3a were examined by CT and tumor marker measurements every six months for the first two years. These examinations were done once a year from the third year to the fifth year. Patients with stage 3b and 3c were examined by CT and tumor marker measurements every four months for the first two years, and every six months from the third year to the fifth year. Statistical analysis - The primary endpoint was anastomotic leakage rate. - The secondary endpoints were operation time, amount of bleeding and 5-year overall survival. To evaluate whether a difference in the operative procedure influences survival including death due to another disease, a comparison of overall survival has meaning. Operation time and amount of bleeding were added to the secondary endpoints because these parameters had a possibility of becoming grounds of selection of the operation method if there were no differences in overall survival. - A sample size of 284 patients was assured to achieve a power of 70% to detect a difference between the groups using a two-sided Chi-squared test with type I error rate equal to 0.05, when the true complication rates were 4% and 12% for the LT and HT groups, respectively. A sample size of 300 patients was assured to achieve a power of 73% to detect a difference in a same condition. The dropouts were considered and the number of accumulation targets was assumed to be 300 patients to keep a power of more than 70%. - For continuous variables, data are presented as means ± standard deviation (SD). For categorical variables, data are presented as frequencies and percentages (%). Comparison of the endpoints was based on intention-to-treat principle, that is, the patients who switched to another group during surgery were treated as members of the allocated group. The Chi-squared test was applied to evaluate the significance of differences in proportions, and t-test was used to evaluate the significance of differences in continuous variables. A p-value of less than 0.05 was considered to be statistically significant.
Trial information was received from ClinicalTrials.gov and was last updated in August 2013.
Information provided to ClinicalTrials.gov by Yokohama City University Medical Center.